Comparative Pharmacology
Head-to-head clinical analysis: NANDROLONE DECANOATE versus STANOZIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NANDROLONE DECANOATE versus STANOZIDE.
NANDROLONE DECANOATE vs STANOZIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nandrolone decanoate is an anabolic-androgenic steroid (AAS) that binds to androgen receptors (AR). Upon binding, it activates AR-mediated gene transcription, leading to increased protein synthesis, muscle growth, and bone density. It also exhibits some estrogenic activity via partial aromatization and progestogenic effects. It stimulates erythropoietin production in kidneys, increasing red blood cell mass.
Androgen receptor agonist; increases protein synthesis and muscle mass by binding to androgen receptors, leading to enhanced nitrogen retention and erythropoiesis.
50-200 mg intramuscularly every 2-4 weeks
100 mg orally twice daily or 200 mg orally once daily; immediate-release formulation.
None Documented
None Documented
Clinical Note
moderateAcarbose + Nandrolone decanoate
"Acarbose may increase the hypoglycemic activities of Nandrolone decanoate."
Clinical Note
moderateSunitinib + Nandrolone decanoate
"Sunitinib may increase the hypoglycemic activities of Nandrolone decanoate."
Clinical Note
moderatePrednisolone + Nandrolone decanoate
"Prednisolone may increase the fluid retaining activities of Nandrolone decanoate."
Clinical Note
moderateDexamethasone + Nandrolone decanoate
Terminal elimination half-life: approximately 6-7 days (range 4-14 days) after intramuscular injection; this long half-life supports every 2-4 week dosing intervals.
Terminal elimination half-life is 24-30 hours, supporting once-daily dosing. Clinical context: Steady-state achieved after approximately 5-7 days.
Renal: ~90% as metabolites (glucuronide and sulfate conjugates of 19-nortestosterone and its metabolites); fecal: ~6%; due to extensive hepatic metabolism, unchanged drug is not excreted in significant amounts.
Primarily hepatic metabolism (approximately 80%) with biliary excretion of metabolites; renal excretion of unchanged drug is minimal (<5%). Fecal elimination accounts for <15%.
Category C
Category C
Anabolic Steroid
Anabolic Steroid
"Dexamethasone may increase the fluid retaining activities of Nandrolone decanoate."